JP2006193435A - 疲労改善剤 - Google Patents
疲労改善剤 Download PDFInfo
- Publication number
- JP2006193435A JP2006193435A JP2005003982A JP2005003982A JP2006193435A JP 2006193435 A JP2006193435 A JP 2006193435A JP 2005003982 A JP2005003982 A JP 2005003982A JP 2005003982 A JP2005003982 A JP 2005003982A JP 2006193435 A JP2006193435 A JP 2006193435A
- Authority
- JP
- Japan
- Prior art keywords
- fatigue
- tomato
- serum
- exercise
- tomato juice
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013305 food Nutrition 0.000 claims abstract description 23
- 230000006872 improvement Effects 0.000 claims abstract description 23
- 230000009471 action Effects 0.000 claims abstract description 11
- 235000015193 tomato juice Nutrition 0.000 claims description 44
- 210000002966 serum Anatomy 0.000 claims description 33
- 235000013361 beverage Nutrition 0.000 claims description 20
- 239000004480 active ingredient Substances 0.000 claims description 9
- 206010016256 fatigue Diseases 0.000 abstract description 87
- 235000007688 Lycopersicon esculentum Nutrition 0.000 abstract description 49
- 240000003768 Solanum lycopersicum Species 0.000 abstract description 49
- 208000019914 Mental Fatigue Diseases 0.000 abstract description 22
- 235000011389 fruit/vegetable juice Nutrition 0.000 abstract description 3
- 230000001747 exhibiting effect Effects 0.000 abstract description 2
- 239000004615 ingredient Substances 0.000 abstract description 2
- 210000004911 serous fluid Anatomy 0.000 abstract description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 60
- 230000000694 effects Effects 0.000 description 34
- 238000012360 testing method Methods 0.000 description 31
- 239000003795 chemical substances by application Substances 0.000 description 26
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 18
- 239000011734 sodium Substances 0.000 description 18
- 229910052708 sodium Inorganic materials 0.000 description 18
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 14
- 239000000047 product Substances 0.000 description 13
- 235000001014 amino acid Nutrition 0.000 description 10
- 229940024606 amino acid Drugs 0.000 description 10
- 150000001413 amino acids Chemical class 0.000 description 10
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 9
- 239000011591 potassium Substances 0.000 description 9
- 229910052700 potassium Inorganic materials 0.000 description 9
- 239000004310 lactic acid Substances 0.000 description 7
- 235000014655 lactic acid Nutrition 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- 238000011084 recovery Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 208000005156 Dehydration Diseases 0.000 description 5
- 230000018044 dehydration Effects 0.000 description 5
- 238000006297 dehydration reaction Methods 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 4
- 235000003704 aspartic acid Nutrition 0.000 description 4
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 4
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 230000000284 resting effect Effects 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 229930091371 Fructose Natural products 0.000 description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 3
- 239000005715 Fructose Substances 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 3
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 3
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 3
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 3
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 3
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 3
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 229960004203 carnitine Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 3
- 229960000310 isoleucine Drugs 0.000 description 3
- 229960004999 lycopene Drugs 0.000 description 3
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 3
- 235000012661 lycopene Nutrition 0.000 description 3
- 239000001751 lycopene Substances 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 3
- 239000004474 valine Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 206010049565 Muscle fatigue Diseases 0.000 description 2
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 229960003121 arginine Drugs 0.000 description 2
- 150000005693 branched-chain amino acids Chemical class 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 229960003624 creatine Drugs 0.000 description 2
- 239000006046 creatine Substances 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 235000013622 meat product Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 235000015113 tomato pastes and purées Nutrition 0.000 description 2
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 208000010428 Muscle Weakness Diseases 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- 241001248610 Ophiocordyceps sinensis Species 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 241001237745 Salamis Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000015241 bacon Nutrition 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 235000020682 bottled natural mineral water Nutrition 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 235000008960 ketchup Nutrition 0.000 description 1
- 229940089442 lacticare Drugs 0.000 description 1
- 229940070036 lycopene 10 mg Drugs 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000036470 plasma concentration Effects 0.000 description 1
- 230000036514 plasma sodium concentration Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 235000015175 salami Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 230000007958 sleep Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 229940026510 theanine Drugs 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
【解決手段】 トマト搾汁液又はその漿液を有効成分として含有する疲労改善剤。
【選択図】 なし
Description
例えば、2−ケトグルタル酸を有効成分とした肉体疲労改善剤(例えば、特許文献1参照)、冬虫夏草およびカイクジンを有効成分とした肉体疲労に対する効き目が増強された内服液(例えば、特許文献2参照)、ビオチン、パントテン酸、カルニチンを有効成分とする疲労改善剤(例えば、特許文献3参照)がある。これらは、肉体的疲労の改善を評価しているが、精神的疲労に対する効果は明記されていない。
本発明の疲労改善剤は、トマト搾汁液又はその漿液を有効成分として含有する。
また、本発明の疲労改善剤に含まれるナトリウムの量は、トマト搾汁液又はその漿液におけるナトリウムの量に相当する10〜100mgの範囲であるとよい。
g/100gの割合で配合させるのが好ましい。
<試験1>
プレ運動30分⇒飲料摂取⇒休憩1時間⇒運動30分⇒疲労感測定
図1中、*は、そのデータがコントロール群と比較して危険率5%以下で有意であることを示す。
尚、上記試験1で使用したトマトジュース100mL中のアミノ酸含有量0.4gの内訳は、セリン10mg、アラニン16mg、アスパラギン酸74mg、グルタミン酸234mg、スレオニン9.1mg、プロリン1.2mg、グリシン1.4mg、リジン7mg、アルギニン2.1mg、アスパラギン34mg、チロシン3.2mg、ヒスチジン2.4mg、フェニルアラニン12mg、メチオニン2mg、システイン4mg、イソロイシン3mg、バリン3mg、ロイシン3mgである。これは上記背景技術欄で挙げた特許文献6に記載のアスパラギン酸を2g/日以上、もしくはアスパラギン酸+グルタミン酸を各1g/日以上、あるいは特許文献7に記載の分岐アミノ酸(ロイシン、イソロイシン、バリン)を500〜2000mg/日、あるいは特許文献8に記載の分岐鎖アミノ酸
(BCAA)を10〜1000mg/Kgの量と比較して、極めて少ない含有量となっており、今回の効果におけるアミノ酸の影響は小さいものと考えられる。
<試験2>
他方、コントロール飲料として、糖+クエン酸液…100mL中:果糖2.0g、ブドウ糖1.6g、クエン酸390mgを用いた。
図2中、*は、そのデータが糖+クエン酸液摂取群と比較して危険率5%以下で有意であることを示す(図3中の*も同義)。
<試験3>
試験飲料は、試験2と同じ3種を用いた。
プレ運動30分⇒試験飲料摂取⇒休憩1時間⇒乳酸値測定⇒運動30分⇒乳酸値
測定⇒休憩1時間⇒乳酸値測定
Claims (3)
- トマト搾汁液又はその漿液を有効成分として含有する疲労改善剤。
- 請求項1に記載の疲労改善剤を含有する疲労改善作用を有する飲食品。
- 請求項1に記載の疲労改善剤を含有する、疲労改善のために用いられるものである旨の表示を付した飲食品。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005003982A JP2006193435A (ja) | 2005-01-11 | 2005-01-11 | 疲労改善剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005003982A JP2006193435A (ja) | 2005-01-11 | 2005-01-11 | 疲労改善剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2006193435A true JP2006193435A (ja) | 2006-07-27 |
Family
ID=36799790
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005003982A Pending JP2006193435A (ja) | 2005-01-11 | 2005-01-11 | 疲労改善剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2006193435A (ja) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2012223140A (ja) * | 2011-04-20 | 2012-11-15 | Ito En Ltd | トマト含有飲料及びその製造方法、並びに、トマト含有飲料の酸味抑制方法 |
| JP2012223142A (ja) * | 2011-04-20 | 2012-11-15 | Ito En Ltd | 脱酸トマト汁及びその製造方法、並びに、トマト含有飲料及びトマト含有飲料の酸味抑制方法 |
| JP2012223144A (ja) * | 2011-04-20 | 2012-11-15 | Ito En Ltd | 脱酸トマト汁及びその製造方法、並びに、トマト含有飲料及びトマト含有飲料の酸味抑制方法 |
| WO2014102546A1 (en) * | 2012-12-24 | 2014-07-03 | Provexis Natural Products Limited | Compositions |
| US10864241B2 (en) | 2012-04-23 | 2020-12-15 | Provexis Natural Products Limited | Use of tomato extract as antihypertensive agent and process for making water soluble sugar free tomato extract |
| US10905733B2 (en) | 2016-11-02 | 2021-02-02 | Provexis Natural Products Limited | Water soluble tomato extract protects against adverse effects of air pollution |
| JP2022053441A (ja) * | 2020-09-24 | 2022-04-05 | 国立大学法人金沢大学 | うつ症状の予防、治療及び/又は緩和用組成物並びに運動量増加組成物 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH099892A (ja) * | 1995-07-01 | 1997-01-14 | Kagome Co Ltd | トマト由来の食品組成物 |
| JP2004059516A (ja) * | 2002-07-30 | 2004-02-26 | Kagome Co Ltd | Age生成阻害剤 |
| WO2004112510A1 (ja) * | 2003-06-19 | 2004-12-29 | Suntory Limited | 運動生理機能向上剤 |
-
2005
- 2005-01-11 JP JP2005003982A patent/JP2006193435A/ja active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH099892A (ja) * | 1995-07-01 | 1997-01-14 | Kagome Co Ltd | トマト由来の食品組成物 |
| JP2004059516A (ja) * | 2002-07-30 | 2004-02-26 | Kagome Co Ltd | Age生成阻害剤 |
| WO2004112510A1 (ja) * | 2003-06-19 | 2004-12-29 | Suntory Limited | 運動生理機能向上剤 |
Non-Patent Citations (11)
| Title |
|---|
| ANN. N. Y. ACAD. SCI., vol. 258, JPN6011012824, 1975, pages 458 - 464, ISSN: 0001867857 * |
| ARCH. BIOCHEM. BIOPHYS., vol. 336, no. 1, JPN6011060430, 1996, pages 1 - 9, ISSN: 0002072993 * |
| J. ENZYM. INHIB., vol. 15, no. 3, JPN6011060433, 2000, pages 283 - 296, ISSN: 0002072997 * |
| 体力科学, vol. 44, no. 1, JPN6011012830, 1995, pages 31 - 33, ISSN: 0001867861 * |
| 医学のあゆみ, vol. 204, no. 5, JPN6011060425, 2003, pages 309 - 313, ISSN: 0002072991 * |
| 医学のあゆみ, vol. 204, no. 5, JPN6011060431, 2003, pages 314 - 318, ISSN: 0002072994 * |
| 園芸学会雑誌, vol. 49, no. 1, JPN6011012829, 1980, pages 85 - 92, ISSN: 0001867860 * |
| 日本農芸化学会誌, vol. 76, no. 7, JPN6011060427, 2002, pages 636 - 639, ISSN: 0002072992 * |
| 果汁協会報, JPN6011012825, 1999, pages 31 - 38, ISSN: 0001867858 * |
| 脳21, vol. 7, no. 1, JPN6012044784, 2004, pages 41 - 45, ISSN: 0002314586 * |
| 農産物流通試験成績書, JPN6011012827, 1992, pages 19 - 24, ISSN: 0001867859 * |
Cited By (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2012223140A (ja) * | 2011-04-20 | 2012-11-15 | Ito En Ltd | トマト含有飲料及びその製造方法、並びに、トマト含有飲料の酸味抑制方法 |
| JP2012223142A (ja) * | 2011-04-20 | 2012-11-15 | Ito En Ltd | 脱酸トマト汁及びその製造方法、並びに、トマト含有飲料及びトマト含有飲料の酸味抑制方法 |
| JP2012223144A (ja) * | 2011-04-20 | 2012-11-15 | Ito En Ltd | 脱酸トマト汁及びその製造方法、並びに、トマト含有飲料及びトマト含有飲料の酸味抑制方法 |
| US10864241B2 (en) | 2012-04-23 | 2020-12-15 | Provexis Natural Products Limited | Use of tomato extract as antihypertensive agent and process for making water soluble sugar free tomato extract |
| CN104870004B (zh) * | 2012-12-24 | 2020-09-04 | 普罗维斯天然产物有限公司 | 组合物 |
| US10813968B2 (en) | 2012-12-24 | 2020-10-27 | Provexis Natural Products Limited | Method of treating a human suffering from post exercise muscle soreness |
| JP2016508976A (ja) * | 2012-12-24 | 2016-03-24 | プロヴェクシス ナチュラル プロダクツ リミテッド | 組成物 |
| GB2511197B (en) * | 2012-12-24 | 2017-05-03 | Provexis Natural Products Ltd | Compositions |
| AU2013369088B2 (en) * | 2012-12-24 | 2018-08-09 | Provexis Natural Products Limited | Compositions |
| JP2019088318A (ja) * | 2012-12-24 | 2019-06-13 | プロヴェクシス ナチュラル プロダクツ リミテッド | 組成物 |
| CN104870004A (zh) * | 2012-12-24 | 2015-08-26 | 普罗维斯天然产物有限公司 | 组合物 |
| KR20150126343A (ko) * | 2012-12-24 | 2015-11-11 | 프로벡시스 내추럴 프로덕츠 리미티드 | 조성물 |
| CN112057521A (zh) * | 2012-12-24 | 2020-12-11 | 普罗维斯天然产物有限公司 | 包含水果提取物的组合物 |
| WO2014102546A1 (en) * | 2012-12-24 | 2014-07-03 | Provexis Natural Products Limited | Compositions |
| CN112057521B (zh) * | 2012-12-24 | 2023-09-08 | 普罗维斯天然产物有限公司 | 包含水果提取物的组合物 |
| EP3777873A1 (en) * | 2012-12-24 | 2021-02-17 | Provexis Natural Products Limited | A composition comprising a tomato extract for preventing systemic inflammation |
| KR102235359B1 (ko) * | 2012-12-24 | 2021-04-02 | 프로벡시스 내추럴 프로덕츠 리미티드 | 조성물 |
| US10905733B2 (en) | 2016-11-02 | 2021-02-02 | Provexis Natural Products Limited | Water soluble tomato extract protects against adverse effects of air pollution |
| JP2022053441A (ja) * | 2020-09-24 | 2022-04-05 | 国立大学法人金沢大学 | うつ症状の予防、治療及び/又は緩和用組成物並びに運動量増加組成物 |
| JP7648129B2 (ja) | 2020-09-24 | 2025-03-18 | 国立大学法人金沢大学 | うつ症状の予防、治療及び/又は緩和用組成物並びに運動量増加組成物 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2873092C (en) | Ketone bodies and ketone body esters for maintaining or improving muscle power output | |
| JP5620647B2 (ja) | 眠気覚まし用組成物 | |
| JP7642730B2 (ja) | ケンペロール類縁体含有組成物 | |
| JP5210636B2 (ja) | 疲労自覚症状改善用組成物 | |
| CN105495582A (zh) | 一款抗疲劳、促恢复的保健食品氨基酸组合物 | |
| JP4739161B2 (ja) | 持久力向上剤 | |
| JP7137483B2 (ja) | アンモニア代謝促進剤 | |
| JPH04278061A (ja) | 栄養食品 | |
| WO2007108530A1 (ja) | 筋肉疲労改善剤 | |
| JP2006193435A (ja) | 疲労改善剤 | |
| JP2005213185A (ja) | エネルギー補給および抗疲労飲食品 | |
| JP4610499B2 (ja) | 食品組成物 | |
| KR102517807B1 (ko) | 신체 에너지 활성 드링크 분말 조성물 및 이를 포함하는 신체 에너지 활성 드링크 분말 | |
| JP2017070271A (ja) | 食品またはサプリメント。 | |
| WO2020091014A1 (ja) | 心拍数低下剤 | |
| WO2015199203A1 (ja) | 眼の疲れ改善剤 | |
| JP6391066B2 (ja) | オルニチン含有体組成改善用組成物 | |
| JP2014114244A (ja) | 抗疲労剤組成物 | |
| JP2013180960A (ja) | 集中力持続性を向上させる作用を有する組成物 | |
| JP2008074733A (ja) | 持久力向上用組成物 | |
| JP2009106253A (ja) | 運動持久力増強効果を有する機能性コーヒー | |
| WO2007029834A1 (ja) | 食品組成物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20071211 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110308 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110427 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20111122 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120119 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20120119 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20120828 |